AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
Depreciation & Amortization
AngioDynamics Inc
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AngioDynamics Inc
NASDAQ:ANGO
|
Depreciation & Amortization
-$10.5m
|
CAGR 3-Years
19%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Depreciation & Amortization
-$897m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-6%
|
|
|
Stryker Corp
NYSE:SYK
|
Depreciation & Amortization
-$732m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-13%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Depreciation & Amortization
-$1.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-11%
|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Depreciation & Amortization
-$700k
|
CAGR 3-Years
51%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AngioDynamics Inc
Glance View
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.
See Also
What is AngioDynamics Inc's Depreciation & Amortization?
Depreciation & Amortization
-10.5m
USD
Based on the financial report for Nov 30, 2025, AngioDynamics Inc's Depreciation & Amortization amounts to -10.5m USD.
What is AngioDynamics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
6%
Over the last year, the Depreciation & Amortization growth was 5%. The average annual Depreciation & Amortization growth rates for AngioDynamics Inc have been 19% over the past three years , 11% over the past five years , and 6% over the past ten years .
